Therapeutic Variables in Cataract Surgery

  • Tell a FriendPrint

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits...

Brief Summary

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind

Intervention(s) in this Clinical Trial

  • Drug: Gatifloxacin
  • Drug: Ketorolac LS
  • Drug: Pred Forte
  • Drug: Moxifloxacin
  • Drug: Nepafenac
  • Drug: EconoPred Plus

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Males or females scheduled to undergo cataract surgery
  • Patients can be receiving monofocal IOLs only
  • Likely to complete all study visits and able to provide informed consent
  • Visual potential of 20/25 or better

Exclusion Criteria:

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Clinical Trial Investigator Information

Lead Investigator: Innovative Medical Industry

Overall Clinical Trial Officials and Contacts

William Trattler, MD Principal Investigator The Center For Excellence in Eye Care  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00407017

Study ID Number: 5264-T

ClinicalTrials.gov Identifier: NCT00407017

Health Authority: United States: Institutional Review Board

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00407017